Valneva joins the phase 3 Covid-19 vaccine club
Meanwhile, Ocugen hopes that Covaxin's India data will be enough for US approval.
Europe needs to be clearer about Covid-19 vaccines
Confusion over blood clot numbers with all four approved Covid-19 vaccines could cause more vaccine hesitancy.
Blood clot fears spread to J&J’s Covid-19 vaccine
The US pauses use of JNJ-78436735 after six cases of cerebral venous sinus thrombosis.
Astra counts the cost of its Covid-19 vaccine
The link between Astrazeneca’s vaccine and blood clots strengthens, but forecasts show that it was never expected to generate huge sales.
Astra’s Covid-19 vaccine: much ado about nothing?
With results of the full primary analysis now out the spotlight falls on a further 14 as yet unadjudicated Covid-19 cases.
Astrazeneca silences its Covid-19 vaccine doubters
AZD1222 could be rehabilitated by US pivotal trial data showing efficacy of 79%, with no worries about blood clots.
